Literature DB >> 8122133

Treatment of acute lymphoblastic leukemia.

D Hoelzer1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8122133

Source DB:  PubMed          Journal:  Semin Hematol        ISSN： 0037-1963            Impact factor:   3.851


× No keyword cloud information.
  8 in total

Review 1.  A potential role of ruxolitinib in leukemia.

Authors:  Kiran Naqvi; Srdan Verstovsek; Hagop Kantarjian; Farhad Ravandi
Journal:  Expert Opin Investig Drugs       Date:  2011-06-03       Impact factor: 6.206

2.  Intensified consolidation therapy with dose-escalated doxorubicin did not improve the prognosis of adults with acute lymphoblastic leukemia: the JALSG-ALL97 study.

Authors:  Itsuro Jinnai; Tohru Sakura; Motohiro Tsuzuki; Yasuhiro Maeda; Noriko Usui; Masayuki Kato; Hirokazu Okumura; Taiichi Kyo; Yasunori Ueda; Yuji Kishimoto; Fumiharu Yagasaki; Kosuke Tsuboi; Shigeo Horiike; Jin Takeuchi; Masako Iwanaga; Yasushi Miyazaki; Shuichi Miyawaki; Kazunori Ohnishi; Tomoki Naoe; Ryuzo Ohno
Journal:  Int J Hematol       Date:  2010-09-10       Impact factor: 2.490

Review 3.  Biology and treatment of adult acute lymphoblastic leukemia.

Authors:  L Levitt; R Lin
Journal:  West J Med       Date:  1996-02

4.  Analysis of 20-year follow-up study of LVP regimen for adult acute lymphoblastic leukemia.

Authors:  Y Hatta; J Takeuchi; T Ohshima; A Horikoshi; Y Iizuka; M Kawamura; M Kanemaru; T Horie
Journal:  Int J Hematol       Date:  2001-08       Impact factor: 2.490

5.  Imatinib mesylate (Gleevec) in the treatment of 2 patients with Philadelphia-positive ALL relapsing after allogeneic stem cell transplantation.

Authors:  Keiji Sugimoto; Michiaki Mikoshiba; Kazuteru Ohashi; Hideki Akiyama; Hisashi Sakamaki
Journal:  Int J Hematol       Date:  2002-05       Impact factor: 2.490

6.  Immunophenotypes and outcome of Philadelphia chromosome-positive and -negative Thai adult acute lymphoblastic leukemia.

Authors:  Chirayu Udomsakdi-Auewarakul; Orathai Promsuwicha; Chintana Tocharoentanaphol; Chanya Munhketvit; Kovit Pattanapanyasat; Surapol Issaragrisil
Journal:  Int J Hematol       Date:  2003-11       Impact factor: 2.490

Review 7.  Treating relapsed or refractory Philadelphia chromosome-negative acute lymphoblastic leukemia: liposome-encapsulated vincristine.

Authors:  Tyler Davis; Sherif S Farag
Journal:  Int J Nanomedicine       Date:  2013-09-16

8.  Treatment outcome of adult acute lymphocytic leukemia with VPD(L) regimen: analysis of prognostic factors.

Authors:  Sook-Ryun Park; Jee Hyun Kim; Do Yeun Kim; Sehoon Lee; Sang-Yoon Lee; In Sil Choi; Sung-Soo Yoon; Seonyang Park; Byuoung-Gook Kim; Noe Kyoung Kim
Journal:  Korean J Intern Med       Date:  2003-03       Impact factor: 2.884
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.